Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. The company offers crude heparin sodium, heparin sodium API, heparin sodium injections, low molecular weight heparin calcium injections, enoxaparin sodium injections, nandroparin calcium injection, dalteparin sodium API and injections, and other products. The company was founded in 2000 and is headquartered in Shijiazhuang, China.

Sector

Healthcare

Industry

Biotechnology

CEO

Gao, Xiaodong

Employees

1,254

Website

www.hbcsbio.com

IPO Date

2011-08-19

Headquarters

Zhengding County High-tech Industrial Development Zone, No. 71, Menglong Street, South District, Zhengding Area, Shijiazhuang, Hebei Province, 050800, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.